NASDAQ:CLXT - Nasdaq - US13173L2060 - Common Stock - Currency: USD
TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 167.00K | 157.00K | 25.99M | 23.85M | 7.30M | |||
Cost Of Goods | 0.00 | 0.00 | 28.56M | 35.13M | 9.28M | |||
Gross Profit | 167.00K | 157.00K | -2.57M | -11.28M | -1.98M | |||
Operating Expenses | 20.91M | 22.53M | 26.76M | 31.86M | 37.69M | |||
Research and Development | 10.82M | 11.55M | 11.34M | 11.08M | 12.21M | |||
Selling, General, and Administrative Expenses | 10.09M | 10.97M | 15.43M | 20.79M | 25.48M | |||
Operating Income | -20.74M | -22.37M | -29.33M | -43.14M | -39.67M | |||
Interest Income/Expense | 4.08M | 5.48M | -1.40M | -1.00M | 60.00K | |||
Non Recurring Items | N/A | 0.00 | 1.53M | -690.00K | N/A | |||
Income Before Taxes | -16.67M | -16.89M | -29.20M | -44.84M | -39.61M | |||
Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Net Income | -16.67M | -16.89M | -29.20M | -44.84M | -39.61M | |||
EBITDA | -19.09M | -20.84M | -26.99M | -41.27M | -38.06M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -3.00 | -3.67 | -7.79 | -1.32 | -1.21 | |||
Non GAAP EPS | -3.04 | -2.09 | -0.88 | -1.32 | -1.21 | |||
Statistics | ||||||||
Gross Profit Margin | 100.00% | 100.00% | -9.89% | -47.30% | -27.12% | |||
Profit Margin | -9979.64% | -10758.60% | -112.36% | -188.01% | -542.60% | |||
Operating Profit Margin | -12421.56% | -14248.41% | -112.87% | -180.88% | -543.42% |
All data in USD